Submission Details
| 510(k) Number | K062347 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 10, 2006 |
| Decision Date | November 22, 2006 |
| Days to Decision | 104 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K062347 is an FDA 510(k) clearance for the ASCENSIA BREEZE 2 BLOOD GLUCOSE MONITORING SYSTEM, a System, Test, Blood Glucose, Over The Counter (Class II — Special Controls, product code NBW), submitted by Bayer Healthcare, LLC (Mishawaka, US). The FDA issued a Cleared decision on November 22, 2006, 104 days after receiving the submission on August 10, 2006. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1345.
| 510(k) Number | K062347 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 10, 2006 |
| Decision Date | November 22, 2006 |
| Days to Decision | 104 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | NBW — System, Test, Blood Glucose, Over The Counter |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1345 |